Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Bgb Strengthens Market Sentiment Improves 20260401 1 Is Invitation Homes Invh Stock Priced Correctly Price At 26.18 Up 0.67 20260410 Is Protagonist Therapeutics Ptgx Stock Consolidating Price At 103.81 Up 0.03 20260406 What Is The Price Target For Crowdstrike Crwd Stock Price At 423.23 Up 6.18 20260407 What Could Push Cadeler Cdlr Stock Higher Price At 23.95 Down 0.66 20260408 What Do Insiders Think About Immatics N.V. Imtx Stock Price At 10.32 Up 0.68 20260408 Will Oxford Oxlci Stock Grow In 2026 Price At 25.40 Up 0.04 20260413 Franklin FRAF Risk Reward Ratio Franklin Financial posts 119 EPS 874M revenue MBI MBIA Inc shares gain 24 percent despite posting a wider than expected Q4 2025 loss Barclays BCS Stock Buy Sell or Hold 340 20260418 BCAX Bicara Therapeutics Inc posts narrow Q4 2025 EPS beat shares tick higher following its quarterly earnings announcement Marine MARPS Stock Volatility Softens 20260418 SDHY PGIM Short posts 151 EPS in Q1 incomefocused strategy supports gains as shares rise 025 Should I hold Valley VLYPP stock today Q4 2025 Profit Surprises Blk Debt DSU Stock What Drives Price RangeBound 20260420 KE Holdings BEKE Stock Bear Call Spread 120 20260420 Does MiMedx Group MDXG stock justify its valuation MiMedx Group posts 167 pct EPS beat on regenerative product strength Linde plc LIN Analyst Price Target Upgrades Reinforce Bullish Case for Defensive Industrial Gas Leader Julong JLHL Stock Valuation The stress test results at Disc Medicine IRON Q1 2026 Earnings Beat Estimates What gross margin for Trinity TRIB Q4 2024 Earnings Fall Short Is BNY Muni Fund DMB stock cheap relative to earnings growth DMB Latest Quarter Earnings BNY Muni Fund results lack consensus EPS and revenue benchmarks KMTS Kestra shares climb 62 percent even as Q1 2026 earnings narrowly fall below analyst estimates How KE Holdings BEKE innovation pipeline shows in financials Q4 2025 EPS Misses Views What Keros Therapeutics KROS does that makes it resilient Flat 20260506 Why Kyivstar KYIV could be the anchor your portfolio needs Ticks Lower 20260508 Why Franklin Res BEN might be the steady performer you need Breakdown Watch 20260508 Central Bankers Sound Alarm on Stagflation and Energy Security Amid Ongoing USIran Conflict Kevin Warsh Fed Chair Prospects Rate Hike Scenario Emerges as Market Expects Cuts Flaherty PFO Slides 071 as Selling Pressure Mounts 20260515 US Appeals Court Pauses Lower Ruling Blocking Trumps 10 Global Tariff US GDP Expanded 2 in Early 2026 Signaling Resilience Amid Global Headwinds Greenidge GREE Reports Strong Q1 2025 Revenue NA EPS Beats Lumentum Holdings LITE Q1 2026 Results Top Views on Strong Revenue Jim Cramer Eyes Bargain Opportunity Stock 10 Off Recent Highs Sparks Buying Interest Dillards DDS Flat at 53322 Consolidation Continues 20260514 Brandywine BDN Q1 2026 Earnings Miss Sparks Concern PBF Energy PBF Stock Suspended Order 106 20260422 ZNTL Zentalis Pharmaceuticals posts smaller Q4 2025 loss than estimates but shares drop 376 percent in todays session J P Morgan JPMD 575 preferred shares stable amid market volatility quarterly dividend commitment unchanged